AGP 9MCY26 profit falls 9% to Rs2.59 billion
Revenue declined 12% to Rs17.98 billion for the nine months ended September 30. Third-quarter profit fell 12% to Rs1.03 billion.

At a glance
- Nine-month net profit declined to Rs2.59 billion from Rs2.85 billion.
- Earnings per share fell to Rs8.29 from Rs8.92.
- Revenue decreased 12% to Rs17.98 billion.
- Third-quarter net profit was Rs1.03 billion, down 12% year on year.
Key facts
- Net profit
- Rs2.59 billion
- 9MCY26, down 9%
- Earnings per share
- Rs8.29
- 9MCY26, down from Rs8.92
- Third-quarter net profit
- Rs1.03 billion
- Q3CY26, down 12%
AGP Limited AGP reported consolidated net profit of Rs2.59 billion for the nine months ended September 30, 2026, a 9% decline from Rs2.85 billion in the same period a year earlier. Basic and diluted earnings per share decreased to Rs8.29 from Rs8.92.
Revenue from contracts with customers fell 12% to Rs17.98 billion. Cost of sales decreased 16% to Rs6.96 billion, while gross profit declined 9% to Rs11.02 billion. The gross profit margin rose to 61.28% from 59.44%.
| Item | 9MCY26 | 9MCY25 | Change |
|---|---|---|---|
| Revenue | Rs17.98 billion | Rs20.34 billion | -11.6% |
| Gross profit | Rs11.02 billion | Rs12.09 billion | -8.9% |
| Net profit | Rs2.59 billion | Rs2.85 billion | -9.4% |
| Earnings per share | Rs8.29 | Rs8.92 | -7.1% |
For Q3CY26, net profit declined 12% to Rs1.03 billion from Rs1.18 billion in Q3CY25, with earnings per share of Rs3.05 compared with Rs3.72. Lower taxation partly cushioned the nine-month earnings decline: total taxation decreased 44% to Rs940.32 million.
Stocks in this story
This story was produced by the Investify News Desk with automated tools and checked against the sources listed. Report an error: support@investify.pk. Editorial policy
More on AGP
AGP 9MCY26 profit dips 9%Mettis• 30 Oct 2026Negative coverage
PACRA retains AGP’s long-term rating at A+Mettis• 27 Oct 2026Neutral coverage
Asian markets mixed, tech stocks tumble on US earnings missesMettis• 30 Oct 2026
HALEON begins Panadol 500mg manufacturing in JamshoroMettis• 30 Oct 2026
Citi Pharma acquires 20% stake in Pakheim InternationalMettis• 30 Oct 2026
Industry seeks NAB probe into alleged overpriced coal purchases at Port Qasim power plantProfit• 30 Oct 2026
